HIGHLIGHTS
- who: Paolo Alonge and collaborators from the University of Palermo, Palermo, Italy have published the research work: Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A Real-Life Single Center Study, in the Journal: (JOURNAL) of 13/07/2020
- what: There were no differences between patients with typical and atypical CIDP phenotype Our data strengthen the the evidence onofthe efficacy of SCIg maintenance therapy in in our population.
- how: At baseline the median nerve (both motor and sensitive) was tested in 60% of patients the ulnar . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.